Skip to NavigationSkip to content

Pharmafile - Research and Development News

Death rates from breast cancer are falling faster in Britain than in any of the other six most populous countries in Europe, according to research...
AstraZeneca has lifted the curtain on new Phase 3 data for its sodium-glucose co-transporter 2 (SGLT2) inhibitor Farxiga (dapagliflozin),...
A shortage of cancer doctors is putting patients at risk, according to a new report from the Royal College of Radiologists (RCR).
Japanese firm Daiichi Sankyo has announced positive results of the first randomised controlled trial of uninterrupted Lixiana (edoxoban) in atrial...
UK-based biotech firm Allergy Therapeutics has been left disappointed after it became evident that its adjuvanted birch allergoid product failed...
Sanofi and Regeneron’s Praluent (alirocumab) has been awarded approval by the European Commission, it has emerged, as a therapy to reduce...
Merck KGaA and AI firm Iktos have entered into a partnership, the pair have announced, to leverage the latter’s generative modelling AI technology...
- 23andMe to offer genetic reports on diabetes - Dutch pharmacists to circumvent Novartis cancer drug market exclusivity - New class of drugs offer...
Celgene’s Abraxane, in combination gemcitabine, has failed to meet its primary endpoint in a pivotal Phase 3 trial of patients with pancreatic cancer.
A new class of cholesterol lowering drugs may help patients who are unable to take statins, according to a study published in the New England...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches